Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 |
|---|---|---|---|---|---|
| 1 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ABL1 1件: ABL1 💬
|
Bosutinib Bosutinib 💬
| Bosutinib | 002 2件: 2 , 67 💬
|
| 2 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ABL1 1件: ABL1 💬
|
Saracatinib Saracatinib 💬
| Saracatinib | 006 3件: 6 , 89, 272 💬
|
| 3 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ABL1 3件: ABL1, KIT, PDGFRA 💬
|
Imatinib Imatinib 💬
| Imatinib | 013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
|
| 4 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ABL1 4件: ABL1, KIT, PDGFRA, PDGFRB 💬
|
Nilotinib Nilotinib 💬
| Nilotinib | 006 5件: 6 , 8 , 34, 51, 86 💬
|
| 5 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ABL1 3件: ABL1, KIT, PDGFRB 💬
|
Dasatinib Dasatinib 💬
| Dasatinib | 051 2件: 51, 85 💬
|
| 6 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ABL1 3件: ABL1, KIT, PDGFRB 💬
|
Dasatinib Dasatinib 💬
| Dasatinib | 051 2件: 51, 85 💬
|
| 7 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AGTR1 1件: AGTR1 💬
|
Angiotensin II Angiotensin II 💬
| Angiotensin II | 017 7件: 17, 19, 46, 66, 86, 222, 224 💬
|
| 8 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AGTR1 1件: AGTR1 💬
|
Angiotensin II Angiotensin II 💬
| Angiotensin II | 017 7件: 17, 19, 46, 66, 86, 222, 224 💬
|
| 9 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AGTR1 1件: AGTR1 💬
|
Candesartan Candesartan 💬
| Candesartan | 058 2件: 58, 67 💬
|
| 10 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AGTR1 1件: AGTR1 💬
|
Candesartan cilexetil Candesartan cilexetil 💬
| Candesartan cilexetil | 067 1件: 67 💬
|
| 11 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AGTR1 1件: AGTR1 💬
|
Irbesartan Irbesartan 💬
| Irbesartan | 066 4件: 66, 167, 168, 222 💬
|
| 12 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AGTR1 1件: AGTR1 💬
|
Losartan Losartan 💬
| Losartan | 017 17件: 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
|
| 13 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AGTR1 1件: AGTR1 💬
|
Telmisartan Telmisartan 💬
| Telmisartan | 066 2件: 66, 67 💬
|
| 14 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AGTR1 1件: AGTR1 💬
|
Valsartan Valsartan 💬
| Valsartan | 057 7件: 57, 58, 66, 75, 218, 222, 224 💬
|
| 15 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AGTR1 2件: AGTR1, EDNRA 💬
|
Sparsentan Sparsentan 💬
| Sparsentan | 066 3件: 66, 218, 222 💬
|
| 16 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ALK 1件: ALK 💬
|
Brigatinib Brigatinib 💬
| Brigatinib | 034 1件: 34 💬
|
| 17 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ALK 1件: ALK 💬
|
Crizotinib Crizotinib 💬
| Crizotinib | 034 1件: 34 💬
|
| 18 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AR 1件: AR 💬
|
Calusterone Calusterone 💬
| Calusterone | 002 1件: 2 💬
|
| 19 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AR 1件: AR 💬
|
Flutamide Flutamide 💬
| Flutamide | 081 1件: 81 💬
|
| 20 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AR 1件: AR 💬
|
Nandrolone Nandrolone 💬
| Nandrolone | 060 2件: 60, 85 💬
|
| 21 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AR 1件: AR 💬
|
Nandrolone decanoate Nandrolone decanoate 💬
| Nandrolone decanoate | 060 2件: 60, 85 💬
|
| 22 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AR 1件: AR 💬
|
Oxandrolone Oxandrolone 💬
| Oxandrolone | 211 2件: 211, 285 💬
|
| 23 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AR 1件: AR 💬
|
Stanozolol Stanozolol 💬
| Stanozolol | 060 1件: 60 💬
|
| 24 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AR 1件: AR 💬
|
Testosterone Testosterone 💬
| Testosterone | 001 8件: 1 , 2 , 3 , 13, 60, 76, 78, 113 💬
|
| 25 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AR 1件: AR 💬
|
Testosterone decanoate Testosterone decanoate 💬
| Testosterone decanoate | 113 1件: 113 💬
|
| 26 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AR 1件: AR 💬
|
Testosterone enanthate Testosterone enanthate 💬
| Testosterone enanthate | 113 1件: 113 💬
|
| 27 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AR 1件: AR 💬
|
Testosterone phenylpropionate Testosterone phenylpropionate 💬
| Testosterone phenylpropionate | 113 1件: 113 💬
|
| 28 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AR 1件: AR 💬
|
Testosterone propionate Testosterone propionate 💬
| Testosterone propionate | 113 1件: 113 💬
|
| 29 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AR 1件: AR 💬
|
Testosterone undecanoate Testosterone undecanoate 💬
| Testosterone undecanoate | 013 2件: 13, 60 💬
|
| 30 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AR 2件: AR, ESR1 💬
|
Danazol Danazol 💬
| Danazol | 060 5件: 60, 63, 64, 65, 285 💬
|
| 31 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AR 3件: AR, ESR1, ESR2 💬
|
Prasterone Prasterone 💬
| Prasterone | 049 6件: 49, 53, 83, 86, 96, 113 💬
|
| 32 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
BCL2 1件: BCL2 💬
|
Venetoclax Venetoclax 💬
| Venetoclax | 028 1件: 28 💬
|
| 33 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
BRAF 1件: BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 1件: 34 💬
|
| 34 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
BRAF 7件: BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 2件: 34, 86 💬
|
| 35 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CASP9 1件: CASP9 💬
|
Rimiducid Rimiducid 💬
| Rimiducid | 019 6件: 19, 60, 65, 284, 285, 326 💬
|
| 36 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CDK4 2件: CDK4, CDK6 💬
|
Abemaciclib Abemaciclib 💬
| Abemaciclib | 034 1件: 34 💬
|
| 37 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CSF1R 7件: CSF1R, FLT3, FLT4, KIT, PDGFRA, PDGFRB, RET 💬
|
Sunitinib Sunitinib 💬
| Sunitinib | 028 2件: 28, 34 💬
|
| 38 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CSF1R 3件: CSF1R, FLT3, KIT 💬
|
Pexidartinib Pexidartinib 💬
| Pexidartinib | 034 1件: 34 💬
|
| 39 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CSF2RA 1件: CSF2RA 💬
|
Mavrilimumab Mavrilimumab 💬
| Mavrilimumab | 041 2件: 41, 46 💬
|
| 40 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CSF2RA 1件: CSF2RA 💬
|
Molgramostim Molgramostim 💬
| Molgramostim | 097 3件: 97, 229, 299 💬
|
| 41 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CSF2RA 1件: CSF2RA 💬
|
Regramostim Regramostim 💬
| Regramostim | 229 1件: 229 💬
|
| 42 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CSF2RA 1件: CSF2RA 💬
|
Sargramostim Sargramostim 💬
| Sargramostim | 006 7件: 6 , 28, 60, 62, 96, 229, 285 💬
|
| 43 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CSF3R 1件: CSF3R 💬
|
Filgrastim Filgrastim 💬
| Filgrastim | 002 35件: 2 , 6 , 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
| 44 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CSF3R 1件: CSF3R 💬
|
Lenograstim Lenograstim 💬
| Lenograstim | 002 7件: 2 , 13, 16, 18, 19, 57, 65 💬
|
| 45 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CSF3R 1件: CSF3R 💬
|
Pegfilgrastim Pegfilgrastim 💬
| Pegfilgrastim | 060 1件: 60 💬
|
| 46 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
CXCR4 1件: CXCR4 💬
|
Plerixafor Plerixafor 💬
| Plerixafor | 019 5件: 19, 20, 65, 285, 299 💬
|
| 47 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
EDNRA 1件: EDNRA 💬
|
Ambrisentan Ambrisentan 💬
| Ambrisentan | 051 7件: 51, 84, 85, 86, 88, 210, 211 💬
|
| 48 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
EDNRA 1件: EDNRA 💬
|
Sitaxentan Sitaxentan 💬
| Sitaxentan | 086 1件: 86 💬
|
| 49 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
EDNRA 1件: EDNRA 💬
|
Zibotentan Zibotentan 💬
| Zibotentan | 051 1件: 51 💬
|
| 50 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬
| Bosentan | 041 10件: 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
| 51 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬
| Bosentan | 041 10件: 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
| 52 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬
| Macitentan | 051 5件: 51, 85, 86, 88, 210 💬
|
| 53 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
EGFR 1件: EGFR 💬
|
Cetuximab Cetuximab 💬
| Cetuximab | 051 2件: 51, 86 💬
|
| 54 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
EGFR 1件: EGFR 💬
|
Erlotinib Erlotinib 💬
| Erlotinib | 094 1件: 94 💬
|
| 55 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
EGFR 1件: EGFR 💬
|
Gefitinib Gefitinib 💬
| Gefitinib | 075 1件: 75 💬
|
| 56 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
EGFR 1件: EGFR 💬
|
Icotinib Icotinib 💬
| Icotinib | 034 1件: 34 💬
|
| 57 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
EGFR 2件: EGFR, ERBB2 💬
|
Lapatinib Lapatinib 💬
| Lapatinib | 034 3件: 34, 74, 75 💬
|
| 58 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
EGFR 2件: EGFR, ERBB2 💬
|
Neratinib Neratinib 💬
| Neratinib | 034 1件: 34 💬
|
| 59 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
EGFR 3件: EGFR, ERBB2, FLT4 💬
|
Tesevatinib Tesevatinib 💬
| Tesevatinib | 067 1件: 67 💬
|
| 60 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
EPOR 1件: EPOR 💬
|
Peginesatide Peginesatide 💬
| Peginesatide | 283 1件: 283 💬
|
| 61 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ESR1 1件: ESR1 💬
|
Desogestrel Desogestrel 💬
| Desogestrel | 230 1件: 230 💬
|
| 62 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ESR1 1件: ESR1 💬
|
Ethinyl estradiol Ethinyl estradiol 💬
| Ethinylestradiol | 013 4件: 13, 46, 49, 299 💬
|
| 63 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ESR1 2件: ESR1, ESR2 💬
|
Clomifene Clomifene 💬
| Clomifene | 074 1件: 74 💬
|
| 64 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ESR1 2件: ESR1, ESR2 💬
|
Estetrol Estetrol 💬
| Estetrol | 053 1件: 53 💬
|
| 65 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ESR1 2件: ESR1, ESR2 💬
|
Estetrol Estetrol 💬
| Estetrol | 053 1件: 53 💬
|
| 66 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ESR1 2件: ESR1, ESR2 💬
|
Estradiol Estradiol 💬
| Estradiol | 013 7件: 13, 46, 49, 65, 76, 226, 299 💬
|
| 67 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ESR1 2件: ESR1, ESR2 💬
|
Estradiol valerate Estradiol valerate 💬
| Estradiol valerate | 065 1件: 65 💬
|
| 68 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ESR1 2件: ESR1, ESR2 💬
|
Estriol Estriol 💬
| Estriol | 013 2件: 13, 227 💬
|
| 69 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ESR1 2件: ESR1, ESR2 💬
|
Estriol tripropionate Estriol tripropionate 💬
| Estriol | 013 2件: 13, 227 💬
|
| 70 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ESR1 2件: ESR1, ESR2 💬
|
Fulvestrant Fulvestrant 💬
| Fulvestrant | 049 2件: 49, 86 💬
|
| 71 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ESR1 2件: ESR1, ESR2 💬
|
Mestranol Mestranol 💬
| Mestranol | 046 2件: 46, 49 💬
|
| 72 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ESR1 2件: ESR1, ESR2 💬
|
Raloxifene Raloxifene 💬
| Raloxifene | 046 1件: 46 💬
|
| 73 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ESR1 2件: ESR1, ESR2 💬
|
Tamoxifen Tamoxifen 💬
| Tamoxifen | 002 3件: 2 , 113, 227 💬
|
| 74 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
F2 1件: F2 💬
|
Dabigatran Dabigatran 💬
| Dabigatran | 051 5件: 51, 75, 85, 91, 124 💬
|
| 75 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
F2 1件: F2 💬
|
Dabigatran etexilate Dabigatran etexilate 💬
| Dabigatran etexilate | 051 2件: 51, 75 💬
|
| 76 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
F2 1件: F2 💬
|
Thrombomodulin alfa Thrombomodulin alfa 💬
| Thrombomodulin Alfa | 085 1件: 85 💬
|
| 77 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
FGF23 1件: FGF23 💬
|
Burosumab Burosumab 💬
| Burosumab | 238 1件: 238 💬
|
| 78 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
FGFR1 3件: FGFR1, FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 79 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
FGFR1 6件: FGFR1, FGFR2, FGFR3, FLT4, PDGFRA, PDGFRB 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 5件: 51, 85, 89, 227, 228 💬
|
| 80 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 5件: 13, 36, 38, 39, 65 💬
|
| 81 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
FLT4 1件: FLT4 💬
|
Axitinib Axitinib 💬
| Axitinib | 034 1件: 34 💬
|
| 82 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
FLT4 1件: FLT4 💬
|
Cediranib Cediranib 💬
| Cediranib | 034 1件: 34 💬
|
| 83 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
HDAC1 2件: HDAC1, HDAC2 💬
|
Vorinostat Vorinostat 💬
| Vorinostat | 075 2件: 75, 96 💬
|
| 84 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
HMOX1 1件: HMOX1 💬
|
Stannsoporfin Stannsoporfin 💬
| Stannsoporfin | 254 1件: 254 💬
|
| 85 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IFNA1 13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬
|
Rontalizumab Rontalizumab 💬
| Rontalizumab | 049 1件: 49 💬
|
| 86 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IFNA1 13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬
|
Sifalimumab Sifalimumab 💬
| Sifalimumab | 049 1件: 49 💬
|
| 87 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Anifrolumab Anifrolumab 💬
| Anifrolumab | 046 3件: 46, 49, 53 💬
|
| 88 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Interferon alfa Interferon alfa 💬
| Interferon alfa | 013 6件: 13, 25, 26, 28, 56, 96 💬
|
| 89 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Interferon alfa-2a Interferon alfa-2a 💬
| Interferon alfa-2a | 056 1件: 56 💬
|
| 90 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Interferon alfa-2b Interferon alfa-2b 💬
| Interferon alfa-2b | 025 2件: 25, 34 💬
|
| 91 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Interferon beta-1a Interferon beta-1a 💬
| Interferon beta-1a | 013 4件: 13, 26, 96, 97 💬
|
| 92 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Interferon beta-1b Interferon beta-1b 💬
| Interferon beta-1b | 013 1件: 13 💬
|
| 93 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IFNAR1 2件: IFNAR1, IFNAR2 💬
|
Peginterferon beta-1a Peginterferon beta-1a 💬
| Peginterferon beta-1a | 013 1件: 13 💬
|
| 94 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IFNG 1件: IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 3件: 49, 65, 107 💬
|
| 95 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IFNG 1件: IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 1件: 46 💬
|
| 96 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IFNGR1 2件: IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 7件: 18, 65, 85, 228, 299, 301, 326 💬
|
| 97 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IGF1R 1件: IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 1件: 232 💬
|
| 98 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IGF1R 1件: IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 6件: 65, 78, 96, 168, 265, 299 💬
|
| 99 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IGF1R 1件: IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 1件: 51 💬
|
| 100 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL12A 3件: IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬
| Ustekinumab | 037 16件: 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
|
| 101 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 102 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 103 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 104 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL23A 1件: IL23A 💬
|
Brazikumab Brazikumab 💬
| Brazikumab | 096 2件: 96, 97 💬
|
| 105 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL23A 1件: IL23A 💬
|
Guselkumab Guselkumab 💬
| Guselkumab | 037 5件: 37, 41, 51, 96, 97 💬
|
| 106 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL23A 1件: IL23A 💬
|
Mirikizumab Mirikizumab 💬
| Mirikizumab | 037 3件: 37, 96, 97 💬
|
| 107 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL23A 1件: IL23A 💬
|
Risankizumab Risankizumab 💬
| Risankizumab | 037 4件: 37, 96, 97, 271 💬
|
| 108 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL23A 1件: IL23A 💬
|
Tildrakizumab Tildrakizumab 💬
| Tildrakizumab | 162 2件: 162, 271 💬
|
| 109 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL2RA 1件: IL2RA 💬
|
Basiliximab Basiliximab 💬
| Basiliximab | 002 6件: 2 , 50, 66, 97, 222, 228 💬
|
| 110 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL2RA 1件: IL2RA 💬
|
Daclizumab Daclizumab 💬
| Daclizumab | 013 8件: 13, 56, 60, 65, 97, 107, 283, 284 💬
|
| 111 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL2RA 3件: IL2RA, IL2RB, IL2RG 💬
|
Aldesleukin Aldesleukin 💬
| Aldesleukin | 002 6件: 2 , 35, 49, 65, 96, 97 💬
|
| 112 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL4 1件: IL4 💬
|
Binetrakin Binetrakin 💬
| Binetrakin | 046 1件: 46 💬
|
| 113 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL4R 1件: IL4R 💬
|
Dupilumab Dupilumab 💬
| Dupilumab | 051 5件: 51, 97, 98, 160, 162 💬
|
| 114 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL5 1件: IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 4件: 44, 45, 98, 162 💬
|
| 115 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL5 1件: IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 2件: 44, 98 💬
|
| 116 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL5RA 1件: IL5RA 💬
|
Benralizumab Benralizumab 💬
| Benralizumab | 044 5件: 44, 45, 98, 162, 299 💬
|
| 117 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL6 1件: IL6 💬
|
Olokizumab Olokizumab 💬
| Olokizumab | 046 2件: 46, 96 💬
|
| 118 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL6 1件: IL6 💬
|
Pirfenidone Pirfenidone 💬
| Pirfenidone | 013 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
| 119 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL6 1件: IL6 💬
|
Pomalidomide Pomalidomide 💬
| Pomalidomide | 028 5件: 28, 51, 85, 227, 331 💬
|
| 120 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL6 1件: IL6 💬
|
Siltuximab Siltuximab 💬
| Siltuximab | 028 2件: 28, 331 💬
|
| 121 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL6 1件: IL6 💬
|
Sirukumab Sirukumab 💬
| Sirukumab | 041 2件: 41, 46 💬
|
| 122 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL6R 1件: IL6R 💬
|
Sarilumab Sarilumab 💬
| Sarilumab | 041 5件: 41, 46, 84, 107, 271 💬
|
| 123 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL6R 1件: IL6R 💬
|
Satralizumab Satralizumab 💬
| Satralizumab | 011 3件: 11, 13, 86 💬
|
| 124 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL6R 1件: IL6R 💬
|
Tocilizumab Tocilizumab 💬
| Tocilizumab | 002 21件: 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
|
| 125 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 1件: JAK1 💬
|
Abrocitinib Abrocitinib 💬
| Abrocitinib | 084 1件: 84 💬
|
| 126 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 1件: JAK1 💬
|
Filgotinib Filgotinib 💬
| Filgotinib | 046 6件: 46, 53, 96, 97, 222, 271 💬
|
| 127 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 1件: JAK1 💬
|
Itacitinib Itacitinib 💬
| Itacitinib | 046 4件: 46, 51, 97, 228 💬
|
| 128 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 1件: JAK1 💬
|
Upadacitinib Upadacitinib 💬
| Upadacitinib | 040 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬
|
| 129 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬
| Baricitinib | 002 13件: 2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
|
| 130 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 2件: JAK1, JAK2 💬
|
Ruxolitinib Ruxolitinib 💬
| Ruxolitinib | 060 3件: 60, 65, 228 💬
|
| 131 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 3件: JAK1, JAK2, JAK3 💬
|
Peficitinib Peficitinib 💬
| Peficitinib | 046 1件: 46 💬
|
| 132 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
JAK1 3件: JAK1, JAK2, JAK3 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
| 133 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
KEAP1 1件: KEAP1 💬
|
Dimethyl fumarate Dimethyl fumarate 💬
| Dimethyl fumarate | 013 5件: 13, 49, 51, 86, 296 💬
|
| 134 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
KIT 1件: KIT 💬
|
Masitinib Masitinib 💬
| Masitinib | 002 6件: 2 , 5 , 6 , 13, 46, 96 💬
|
| 135 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
MAP2K1 2件: MAP2K1, MAP2K2 💬
|
Binimetinib Binimetinib 💬
| Binimetinib | 034 1件: 34 💬
|
| 136 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
MAP2K1 2件: MAP2K1, MAP2K2 💬
|
Cobimetinib Cobimetinib 💬
| Cobimetinib | 280 1件: 280 💬
|
| 137 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
MAP2K1 2件: MAP2K1, MAP2K2 💬
|
Mirdametinib Mirdametinib 💬
| Mirdametinib | 034 1件: 34 💬
|
| 138 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
MAP2K1 2件: MAP2K1, MAP2K2 💬
|
Selumetinib Selumetinib 💬
| Selumetinib | 034 1件: 34 💬
|
| 139 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
MAP2K1 2件: MAP2K1, MAP2K2 💬
|
Trametinib Trametinib 💬
| Trametinib | 002 4件: 2 , 34, 279, 280 💬
|
| 140 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
MET 1件: MET 💬
|
Cabozantinib Cabozantinib 💬
| Cabozantinib | 034 1件: 34 💬
|
| 141 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
MTOR 1件: MTOR 💬
|
Everolimus Everolimus 💬
| Everolimus | 034 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
|
| 142 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
MTOR 1件: MTOR 💬
|
Sirolimus Sirolimus 💬
| Sirolimus | 002 40件: 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬
|
| 143 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
MTOR 1件: MTOR 💬
|
Temsirolimus Temsirolimus 💬
| Temsirolimus | 013 1件: 13 💬
|
| 144 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
NFE2L2 1件: NFE2L2 💬
|
Omaveloxolone Omaveloxolone 💬
| Omaveloxolone | 018 1件: 18 💬
|
| 145 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
NFKB1 1件: NFKB1 💬
|
Iguratimod Iguratimod 💬
| Iguratimod | 046 5件: 46, 51, 53, 271, 300 💬
|
| 146 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
NQO1 1件: NQO1 💬
|
Warfarin Warfarin 💬
| Warfarin | 006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 86, 88, 91 💬
|
| 147 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PGF 3件: PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 148 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PIK3CA 1件: PIK3CA 💬
|
Alpelisib Alpelisib 💬
| Alpelisib | 138 1件: 138 💬
|
| 149 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PIK3CA 3件: PIK3CA, PIK3CB, PIK3CD 💬
|
Leniolisib Leniolisib 💬
| Leniolisib | 053 2件: 53, 65 💬
|
| 150 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PIK3CD 1件: PIK3CD 💬
|
Parsaclisib Parsaclisib 💬
| Parsaclisib | 035 3件: 35, 53, 61 💬
|
| 151 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PML 3件: PML, RARA, RARB 💬
|
Tretinoin Tretinoin 💬
| Tretinoin | 002 6件: 2 , 62, 63, 75, 94, 231 💬
|
| 152 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PPARG 1件: PPARG 💬
|
Bocidelpar Bocidelpar 💬
| Bocidelpar | 113 1件: 113 💬
|
| 153 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PPARG 1件: PPARG 💬
|
Leriglitazone Leriglitazone 💬
| Leriglitazone | 020 1件: 20 💬
|
| 154 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PPARG 1件: PPARG 💬
|
Pioglitazone Pioglitazone 💬
| Pioglitazone | 002 17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
|
| 155 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PPARG 1件: PPARG 💬
|
Rosiglitazone Rosiglitazone 💬
| Rosiglitazone | 046 5件: 46, 75, 97, 222, 265 💬
|
| 156 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PPARG 1件: PPARG 💬
|
Seladelpar Seladelpar 💬
| Seladelpar | 093 2件: 93, 94 💬
|
| 157 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PRKCB 1件: PRKCB 💬
|
Enzastaurin Enzastaurin 💬
| Enzastaurin | 168 1件: 168 💬
|
| 158 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGER1 1件: PTGER1 💬
|
Alprostadil Alprostadil 💬
| Alprostadil | 051 2件: 51, 70 💬
|
| 159 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGER1 1件: PTGER1 💬
|
Limaprost Limaprost 💬
| Limaprost | 070 1件: 70 💬
|
| 160 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGER2 3件: PTGER2, PTGER3, PTGER4 💬
|
Misoprostol Misoprostol 💬
| Misoprostol | 046 3件: 46, 70, 271 💬
|
| 161 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Aceclofenac Aceclofenac 💬
| Aceclofenac | 046 1件: 46 💬
|
| 162 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Acetaminophen Acetaminophen 💬
| Acetaminophen | 003 15件: 3 , 6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
|
| 163 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Aspirin Aspirin 💬
| Acetylsalicylic acid | 013 14件: 13, 22, 46, 49, 51, 58, 64, 86, 97, 113, 158, 210, 231, 251 💬
|
| 164 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Celecoxib Celecoxib 💬
| Celecoxib | 002 10件: 2 , 3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
|
| 165 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Diclofenac Diclofenac 💬
| Diclofenac | 013 5件: 13, 34, 46, 78, 271 💬
|
| 166 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Diflunisal Diflunisal 💬
| Diflunisal | 028 1件: 28 💬
|
| 167 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Etodolac Etodolac 💬
| Etodolac | 046 1件: 46 💬
|
| 168 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Etoricoxib Etoricoxib 💬
| Etoricoxib | 046 2件: 46, 271 💬
|
| 169 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Flurbiprofen Flurbiprofen 💬
| Flurbiprofen | 013 3件: 13, 21, 46 💬
|
| 170 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Ibuprofen Ibuprofen 💬
| Ibuprofen | 013 7件: 13, 46, 65, 107, 113, 271, 299 💬
|
| 171 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Indomethacin Indomethacin 💬
| Indomethacin | 225 3件: 225, 271, 298 💬
|
| 172 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Ketoprofen Ketoprofen 💬
| Ketoprofen | 046 1件: 46 💬
|
| 173 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Ketorolac Ketorolac 💬
| Ketorolac | 070 2件: 70, 226 💬
|
| 174 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Loxoprofen Loxoprofen 💬
| Loxoprofen | 046 2件: 46, 271 💬
|
| 175 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Lumiracoxib Lumiracoxib 💬
| Lumiracoxib | 046 1件: 46 💬
|
| 176 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Meloxicam Meloxicam 💬
| Meloxicam | 046 4件: 46, 49, 271, 296 💬
|
| 177 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Naproxen Naproxen 💬
| Naproxen | 013 4件: 13, 46, 107, 271 💬
|
| 178 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Nimesulide Nimesulide 💬
| Nimesulide | 046 1件: 46 💬
|
| 179 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Parecoxib Parecoxib 💬
| Parecoxib | 046 2件: 46, 271 💬
|
| 180 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Rofecoxib Rofecoxib 💬
| Rofecoxib | 046 1件: 46 💬
|
| 181 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Salsalate Salsalate 💬
| Salsalate | 005 1件: 5 💬
|
| 182 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Sulindac Sulindac 💬
| Sulindac | 206 1件: 206 💬
|
| 183 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Tolfenamic acid Tolfenamic acid 💬
| Tolfenamic acid | 005 1件: 5 💬
|
| 184 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PTGS2 1件: PTGS2 💬
|
Valdecoxib Valdecoxib 💬
| Valdecoxib | 046 1件: 46 💬
|
| 185 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
RARA 1件: RARA 💬
|
Tamibarotene Tamibarotene 💬
| Tamibarotene | 026 2件: 26, 96 💬
|
| 186 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
RARA 2件: RARA, RARB 💬
|
Fenretinide Fenretinide 💬
| Fenretinide | 299 1件: 299 💬
|
| 187 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
RARA 2件: RARA, RARB 💬
|
Isotretinoin Isotretinoin 💬
| Isotretinoin | 036 4件: 36, 39, 159, 160 💬
|
| 188 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
RARA 2件: RARA, RARB 💬
|
Vitamin A Vitamin A 💬
| Vitamin A | 013 3件: 13, 53, 90 💬
|
| 189 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
RARA 5件: RARA, RARB, RXRA, RXRB, RXRG 💬
|
Acitretin Acitretin 💬
| Acitretin | 037 1件: 37 💬
|
| 190 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
RARA 5件: RARA, RARB, RXRA, RXRB, RXRG 💬
|
Alitretinoin Alitretinoin 💬
| Alitretinoin | 049 1件: 49 💬
|
| 191 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
RELA 1件: RELA 💬
|
Edasalonexent Edasalonexent 💬
| Edasalonexent | 113 1件: 113 💬
|
| 192 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ROCK1 2件: ROCK1, ROCK2 💬
|
Fasudil Fasudil 💬
| Fasudil | 002 4件: 2 , 5 , 7 , 51 💬
|
| 193 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
ROCK2 1件: ROCK2 💬
|
Belumosudil Belumosudil 💬
| Belumosudil | 051 2件: 51, 85 💬
|
| 194 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
RXRA 3件: RXRA, RXRB, RXRG 💬
|
Bexarotene Bexarotene 💬
| Bexarotene | 013 2件: 13, 75 💬
|
| 195 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
SMO 1件: SMO 💬
|
Taladegib Taladegib 💬
| Taladegib | 085 1件: 85 💬
|
| 196 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
SMO 1件: SMO 💬
|
Vismodegib Vismodegib 💬
| Vismodegib | 085 1件: 85 💬
|
| 197 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
TGFB1 3件: TGFB1, TGFB2, TGFB3 💬
|
Fresolimumab Fresolimumab 💬
| Fresolimumab | 051 3件: 51, 85, 222 💬
|
| 198 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 199 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|